Symtuza: payments to doctors
Payments that named Symtuza as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7M
- Providers
- 5,763
- Transactions
- 61,529
- Average per transaction
- $114
The per-transaction average — $114 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,763 providers the average total is $1,221, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Janssen Products, LP | $4,841,743 | 68.8% |
| Johnson & Johnson | $1,300,924 | 18.5% |
| Janssen Scientific Affairs, LLC | $894,598 | 12.7% |
| Johnson & Johnson Surgical Vision, Inc. | $111 | 0.0% |